What is Cosmos Health Inc.'s earnings per share (EPS)?

Cosmos Health Inc. (COSM) reported diluted earnings per share of $-0.63 for fiscal year 2025. This represents a 46.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cosmos Health Inc. Financials

COSM

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Cosmos Health Inc. (COSM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI COSM FY2025 2026-05-20

Revenue growth is not yet overcoming a thin gross margin structure, so the business still leans on external financing.

Between FY2024 and FY2025, gross margin recovered from 7.9% to 12.1% as revenue also moved higher. Yet operating cash burn stayed near -$8.4M and net loss widened to -$19.1M, showing that better gross economics still were not enough to fund the cost structure.

The balance sheet looks liquid only on paper: FY2025 cash was just $716K with a current ratio of 1.0x, so near-term obligations were barely covered without turning receivables into cash. With accounts receivable at $19.6M and cash tiny, day-to-day flexibility depends heavily on collections rather than a cash buffer.

The apparent per-share improvement is not the same as profit improvement: FY2025 net loss was -$19.1M versus -$16.2M in FY2024. Diluted shares rose to 41.1M from 23.6M, which helps explain why EPS looked less negative even as the business lost more money.

Financial Health Signals

Financial Profile 27/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Cosmos Health Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Cosmos Health Inc. has an operating margin of -25.6%, meaning the company retains $-26 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -28.6% the prior year.

Growth

Cosmos Health Inc.'s revenue surged 19.9% year-over-year to $65.3M, reflecting rapid business expansion. This strong growth earns a score of 51/100.

Leverage

Cosmos Health Inc. carries a low D/E ratio of 0.20, meaning only $0.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Cosmos Health Inc.'s current ratio of 1.00 is below the typical benchmark, resulting in a score of 15/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

While Cosmos Health Inc. generated -$8.4M in operating cash flow, capex of $56K consumed most of it, leaving -$8.5M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Cosmos Health Inc. generates a -103.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -66.0% the prior year.

Piotroski F-Score Neutral

6/9

Cosmos Health Inc. passes 6 of 9 financial strength tests. 2 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.44x

For every $1 of reported earnings, Cosmos Health Inc. generates $0.44 in operating cash flow (-$8.4M OCF vs -$19.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-8.8x

Cosmos Health Inc. earns $-8.8 in operating income for every $1 of interest expense (-$16.7M vs $1.9M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$65.3M

YoY+19.9%

5Y CAGR+3.3%

10Y CAGR+61.7%

Cosmos Health Inc. generated $65.3M in revenue in fiscal year 2025. This represents an increase of 19.9% from the prior year.

EBITDA

-$15.3M

YoY-7.1%

Cosmos Health Inc.'s EBITDA was -$15.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.1% from the prior year.

Net Income

-$19.1M

YoY-18.3%

Cosmos Health Inc. reported -$19.1M in net income in fiscal year 2025. This represents a decrease of 18.3% from the prior year.

EPS (Diluted)

$-0.63

YoY+46.2%

Cosmos Health Inc. earned $-0.63 per diluted share (EPS) in fiscal year 2025. This represents an increase of 46.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$8.5M

YoY-4.5%

Cosmos Health Inc. generated -$8.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 4.5% from the prior year.

Cash & Debt

$716K

YoY+127.1%

5Y CAGR+2.6%

10Y CAGR+13.7%

Cosmos Health Inc. held $716K in cash against $3.8M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

24M

YoY+0.0%

Cosmos Health Inc. had 24M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

12.1%

YoY+4.2pp

5Y CAGR-2.4pp

10Y CAGR+2.9pp

Cosmos Health Inc.'s gross margin was 12.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 4.2 percentage points from the prior year.

Operating Margin

-25.6%

YoY+3.0pp

5Y CAGR-30.5pp

10Y CAGR+57.3pp

Cosmos Health Inc.'s operating margin was -25.6% in fiscal year 2025, reflecting core business profitability. This is up 3.0 percentage points from the prior year.

Net Margin

-29.3%

YoY+0.4pp

5Y CAGR-30.8pp

Cosmos Health Inc.'s net profit margin was -29.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.4 percentage points from the prior year.

Return on Equity

-103.9%

YoY-37.9pp

Cosmos Health Inc.'s ROE was -103.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 37.9 percentage points from the prior year.

Capital Allocation

R&D Spending

$519K

YoY-2.6%

Cosmos Health Inc. invested $519K in research and development in fiscal year 2025. This represents a decrease of 2.6% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$56K

YoY-86.7%

5Y CAGR-13.9%

10Y CAGR+2.4%

Cosmos Health Inc. invested $56K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 86.7% from the prior year.

COSM Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$65.3M+19.9%	$54.4M+2.0%	$53.4M+6.0%	$50.3M-10.5%	$56.2M+1.5%	$55.4M
Cost of Revenue	$57.4M+14.5%	$50.1M+2.2%	$49.0M+10.4%	$44.4M-7.3%	$47.9M+1.2%	$47.3M
Gross Profit	$7.9M+83.1%	$4.3M-0.9%	$4.3M-27.0%	$6.0M-28.5%	$8.3M+3.4%	$8.1M
R&D Expenses	$519K-2.6%	$533K+223.5%	$165K	N/A	N/A	N/A
SG&A Expenses	$15.6M+33.1%	$11.7M-40.3%	$19.6M+92.9%	$10.2M+10.6%	$9.2M+337.9%	$2.1M
Operating Income	-$16.7M-7.5%	-$15.5M+28.8%	-$21.8M-192.1%	-$7.5M-64.9%	-$4.5M-267.0%	$2.7M
Interest Expense	$1.9M+87.7%	$1.0M+16.8%	$866K-63.1%	$2.3M-16.9%	$2.8M+2.3%	$2.8M
Income Tax	$0	$0	$0+100.0%	-$775K-779.8%	$114K+130.2%	-$378K
Net Income	-$19.1M-18.3%	-$16.2M+12.7%	-$18.5M-34.1%	-$13.8M-73.7%	-$8.0M-1070.0%	$821K
EPS (Diluted)	$-0.63+46.2%	$-1.17+45.6%	$-2.15+93.5%	$-33.16	$-23.74	$0.06

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$17.9M-9.0%	$19.7M+15.2%	$17.1M+16.0%	$14.7M+7.5%	$13.7M-3.6%	$14.2M+14.6%	$12.4M-6.0%	$13.2M
Cost of Revenue	$16.5M-6.1%	$17.6M+21.5%	$14.5M+6.8%	$13.6M+16.5%	$11.7M-11.8%	$13.2M+18.0%	$11.2M-9.9%	$12.4M
Gross Profit	$1.4M-33.6%	$2.1M-20.1%	$2.6M+123.6%	$1.2M-43.2%	$2.0M+104.2%	$1.0M-16.8%	$1.2M+57.3%	$767K
R&D Expenses	$0-100.0%	$411K+2140.1%	$18K-75.4%	$75K+377.6%	$16K-97.1%	$533K	$0	$0
SG&A Expenses	$1.8M-83.0%	$10.6M+420.0%	$2.0M+36.9%	$1.5M+0.8%	$1.5M-79.3%	$7.1M+300.5%	$1.8M+28.2%	$1.4M
Operating Income	-$2.2M+80.9%	-$11.4M-527.2%	-$1.8M+31.2%	-$2.6M-217.5%	-$833K+90.7%	-$9.0M-300.3%	-$2.2M+10.5%	-$2.5M
Interest Expense	$423K-35.4%	$655K-2.1%	$669K+72.1%	$389K+107.8%	$187K-41.5%	$320K+76.2%	$181K-47.0%	$342K
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$2.8M+72.3%	-$10.1M-89.5%	-$5.4M-89.3%	-$2.8M-245.7%	-$818K+75.6%	-$3.3M+60.0%	-$8.4M-223.4%	-$2.6M
EPS (Diluted)	$-0.06	N/A	$-0.17-70.0%	$-0.10-233.3%	$-0.03	N/A	$-0.45-200.0%	$-0.15

COSM Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$65.5M+20.6%	$54.3M-17.7%	$66.0M-3.0%	$68.0M+37.6%	$49.4M+12.7%	$43.8M
Current Assets	$38.4M+50.8%	$25.5M-30.4%	$36.6M-35.1%	$56.4M+41.5%	$39.8M-2.3%	$40.8M
Cash & Equivalents	$716K+127.1%	$315K-91.8%	$3.8M-81.5%	$20.7M+7142.8%	$286K-54.4%	$628K
Inventory	$5.8M+32.7%	$4.4M-9.1%	$4.8M+38.7%	$3.5M+9.7%	$3.1M-4.4%	$3.3M
Accounts Receivable	$19.6M+45.6%	$13.5M-31.8%	$19.8M-16.6%	$23.7M-10.6%	$26.5M+13.0%	$23.4M
Goodwill	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K
Total Liabilities	$47.1M+58.0%	$29.8M-0.6%	$30.0M+5.6%	$28.4M-37.0%	$45.0M-6.2%	$48.0M
Current Liabilities	$38.3M+48.6%	$25.8M+5.9%	$24.3M+11.8%	$21.7M-27.3%	$29.9M-12.7%	$34.3M
Long-Term Debt	$3.8M-8.1%	$4.1M+209.5%	$1.3M-73.5%	$5.0M+950.6%	$478K-95.6%	$10.8M
Total Equity	$18.4M-24.9%	$24.5M-31.9%	$36.0M-8.3%	$39.3M+797.0%	$4.4M+205.2%	-$4.2M
Retained Earnings	-$133.2M-16.8%	-$114.0M-24.4%	-$91.6M-38.4%	-$66.2M-92.8%	-$34.3M-83.2%	-$18.8M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$62.4M-4.7%	$65.5M-5.8%	$69.5M+12.4%	$61.8M+8.1%	$57.2M+5.3%	$54.3M-15.8%	$64.5M+6.1%	$60.8M
Current Assets	$36.9M-3.9%	$38.4M+0.7%	$38.1M+24.7%	$30.6M+9.8%	$27.8M+9.4%	$25.5M-29.7%	$36.2M+8.5%	$33.4M
Cash & Equivalents	$515K-28.1%	$716K-19.5%	$889K+35.7%	$656K-11.8%	$743K+135.8%	$315K-90.5%	$3.3M+865.0%	$344K
Inventory	$5.7M-2.2%	$5.8M+1.7%	$5.7M+11.2%	$5.1M+7.9%	$4.7M+8.7%	$4.4M-10.8%	$4.9M+13.0%	$4.3M
Accounts Receivable	$18.2M-7.3%	$19.6M+8.9%	$18.0M+16.7%	$15.5M+8.4%	$14.3M+5.7%	$13.5M-22.9%	$17.5M-4.9%	$18.4M
Goodwill	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K
Total Liabilities	$42.5M-9.6%	$47.1M+1.5%	$46.4M+30.2%	$35.6M+14.0%	$31.2M+4.9%	$29.8M+0.8%	$29.5M+2.9%	$28.7M
Current Liabilities	$34.1M-11.0%	$38.3M-0.7%	$38.5M+23.6%	$31.2M+17.2%	$26.6M+3.2%	$25.8M+2.2%	$25.2M+1.6%	$24.8M
Long-Term Debt	$3.5M-8.6%	$3.8M-29.6%	$5.4M+3.4%	$5.2M+7.0%	$4.9M+18.1%	$4.1M-3.7%	$4.3M+8.5%	$3.9M
Total Equity	$19.8M+7.6%	$18.4M-20.4%	$23.1M-11.8%	$26.2M+1.1%	$26.0M+5.8%	$24.5M-29.9%	$35.0M+8.9%	$32.1M
Retained Earnings	-$136.0M-2.1%	-$133.2M-8.2%	-$123.0M-4.5%	-$117.7M-2.5%	-$114.8M-0.7%	-$114.0M-9.1%	-$104.5M-8.7%	-$96.1M

COSM Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$8.4M-9.5%	-$7.7M+50.6%	-$15.6M-5.1%	-$14.9M-109.5%	-$7.1M+38.3%	-$11.5M
Capital Expenditures	$56K-86.7%	$418K-68.2%	$1.3M+1669.6%	$74K-87.2%	$581K+393.8%	$118K
Free Cash Flow	-$8.5M-4.5%	-$8.1M+52.0%	-$16.9M-13.4%	-$14.9M-94.6%	-$7.7M+33.9%	-$11.6M
Investing Cash Flow	-$2.0M-152.4%	-$798K+94.2%	-$13.8M-63910.6%	-$21K+97.4%	-$827K-602.2%	-$118K
Financing Cash Flow	$14.1M+178.5%	$5.0M-60.2%	$12.7M-63.8%	$35.0M+382.2%	$7.3M-41.7%	$12.5M
Dividends Paid	N/A	N/A	N/A	$5.8M	N/A	N/A
Share Buybacks	N/A	$0-100.0%	$100K	N/A	$377K+88.4%	$200K

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$1.1M+76.8%	-$4.6M-87.2%	-$2.5M-102.9%	-$1.2M-549.4%	-$186K+95.1%	-$3.8M-618.2%	$740K+161.1%	-$1.2M
Capital Expenditures	$11K+44.4%	$8K-37.9%	$13K-43.6%	$23K+79.8%	$13K-82.7%	$72K-68.3%	$229K+569.6%	$34K
Free Cash Flow	-$1.1M+76.6%	-$4.6M-86.6%	-$2.5M-100.2%	-$1.2M-519.8%	-$199K+94.9%	-$3.9M-864.4%	$511K+141.0%	-$1.2M
Investing Cash Flow	-$709K+33.7%	-$1.1M-5.9%	-$1.0M-1506.3%	$72K+1116.0%	-$7K+99.3%	-$1.0M-2737.0%	-$35K-130.6%	$116K
Financing Cash Flow	$348K-92.6%	$4.7M-34.7%	$7.2M+348.3%	$1.6M+186.1%	$561K-65.4%	$1.6M-39.6%	$2.7M+396.6%	$540K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$0	N/A	N/A

COSM Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	12.1%+4.2pp	7.9%-0.2pp	8.2%-3.7pp	11.8%-3.0pp	14.8%+0.3pp	14.5%
Operating Margin	-25.6%+3.0pp	-28.6%+12.3pp	-40.9%-26.1pp	-14.8%-6.8pp	-8.1%-13.0pp	4.9%
Net Margin	-29.3%+0.4pp	-29.7%+5.0pp	-34.7%-7.3pp	-27.5%-13.3pp	-14.2%-15.6pp	1.5%
Return on Equity	-103.9%-37.9pp	-66.0%-14.5pp	-51.4%-16.2pp	-35.2%+146.6pp	-181.8%	N/A
Return on Assets	-29.2%+0.6pp	-29.8%-1.7pp	-28.1%-7.8pp	-20.3%-4.2pp	-16.1%-18.0pp	1.9%
Current Ratio	1.00+0.0	0.99-0.5	1.51-1.1	2.59+1.3	1.33+0.1	1.19
Debt-to-Equity	0.20+0.0	0.17+0.1	0.04-0.1	0.13+0.0	0.11+2.7	-2.59
FCF Margin	-13.0%+1.9pp	-14.9%+16.8pp	-31.8%-2.1pp	-29.7%-16.0pp	-13.7%+7.3pp	-21.0%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	7.7%-2.8pp	10.5%-4.7pp	15.2%+7.3pp	7.9%-7.1pp	14.9%+7.9pp	7.1%-2.7pp	9.7%+3.9pp	5.8%
Operating Margin	-12.2%+45.7pp	-57.9%-47.3pp	-10.6%+7.3pp	-17.9%-11.9pp	-6.1%+57.0pp	-63.0%-45.0pp	-18.1%+0.9pp	-18.9%
Net Margin	-15.7%+35.8pp	-51.5%-20.2pp	-31.3%-12.1pp	-19.2%-13.2pp	-6.0%+17.6pp	-23.5%+44.0pp	-67.5%-47.9pp	-19.6%
Return on Equity	-14.1%+40.9pp	-55.1%-31.9pp	-23.1%-12.4pp	-10.8%-7.6pp	-3.1%+10.5pp	-13.6%+10.3pp	-23.9%-15.9pp	-8.1%
Return on Assets	-4.5%+11.0pp	-15.5%-7.8pp	-7.7%-3.1pp	-4.6%-3.1pp	-1.4%+4.7pp	-6.2%+6.8pp	-13.0%-8.7pp	-4.3%
Current Ratio	1.08+0.1	1.00+0.0	0.990.0	0.98-0.1	1.05+0.1	0.99-0.4	1.44+0.1	1.35
Debt-to-Equity	0.17-0.0	0.20-0.0	0.23+0.0	0.20+0.0	0.19+0.0	0.17+0.0	0.120.0	0.12
FCF Margin	-6.0%+17.3pp	-23.4%-8.9pp	-14.4%-6.1pp	-8.4%-6.9pp	-1.5%+26.0pp	-27.5%-31.6pp	4.1%+13.6pp	-9.4%

Similar Companies

Synergy Chc Corp SNYR

$3.9M

Zynex Inc ZYXI

$3.8M

111 YI

$46.9M

Edap Tms EDAP

$161.5M

Quipt Home Medical Corp QIPT

$162.3M

Frequently Asked Questions

What is Cosmos Health Inc.'s annual revenue?

Cosmos Health Inc. (COSM) reported $65.3M in total revenue for fiscal year 2025. This represents a 19.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cosmos Health Inc.'s revenue growing?

Cosmos Health Inc. (COSM) revenue grew by 19.9% year-over-year, from $54.4M to $65.3M in fiscal year 2025.

Is Cosmos Health Inc. profitable?

No, Cosmos Health Inc. (COSM) reported a net income of -$19.1M in fiscal year 2025, with a net profit margin of -29.3%.

What is Cosmos Health Inc.'s EBITDA?

Cosmos Health Inc. (COSM) had EBITDA of -$15.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cosmos Health Inc. have?

As of fiscal year 2025, Cosmos Health Inc. (COSM) had $716K in cash and equivalents against $3.8M in long-term debt.

What is Cosmos Health Inc.'s gross margin?

Cosmos Health Inc. (COSM) had a gross margin of 12.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cosmos Health Inc.'s operating margin?

Cosmos Health Inc. (COSM) had an operating margin of -25.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cosmos Health Inc.'s net profit margin?

Cosmos Health Inc. (COSM) had a net profit margin of -29.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Cosmos Health Inc.'s return on equity (ROE)?

Cosmos Health Inc. (COSM) has a return on equity of -103.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cosmos Health Inc.'s free cash flow?

Cosmos Health Inc. (COSM) generated -$8.5M in free cash flow during fiscal year 2025. This represents a -4.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cosmos Health Inc.'s operating cash flow?

Cosmos Health Inc. (COSM) generated -$8.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Cosmos Health Inc.'s total assets?

Cosmos Health Inc. (COSM) had $65.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Cosmos Health Inc.'s capital expenditures?

Cosmos Health Inc. (COSM) invested $56K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Cosmos Health Inc. spend on research and development?

Cosmos Health Inc. (COSM) invested $519K in research and development during fiscal year 2025.

How many shares does Cosmos Health Inc. have outstanding?

Cosmos Health Inc. (COSM) had 24M shares outstanding as of fiscal year 2025.

What is Cosmos Health Inc.'s current ratio?

Cosmos Health Inc. (COSM) had a current ratio of 1.00 as of fiscal year 2025, which is considered adequate.

What is Cosmos Health Inc.'s debt-to-equity ratio?

Cosmos Health Inc. (COSM) had a debt-to-equity ratio of 0.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cosmos Health Inc.'s return on assets (ROA)?

Cosmos Health Inc. (COSM) had a return on assets of -29.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cosmos Health Inc.'s cash runway?

Based on fiscal year 2025 data, Cosmos Health Inc. (COSM) had $716K in cash against an annual operating cash burn of $8.4M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Cosmos Health Inc.'s Piotroski F-Score?

Cosmos Health Inc. (COSM) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cosmos Health Inc.'s earnings high quality?

Cosmos Health Inc. (COSM) has an earnings quality ratio of 0.44x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cosmos Health Inc. cover its interest payments?

Cosmos Health Inc. (COSM) has an interest coverage ratio of -8.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Cosmos Health Inc.?

Cosmos Health Inc. (COSM) scores 27 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.